Axitinib. PubMed Health website. Available at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0046824/. Accessed September 19, 2012.
Baudin E, Schlumberger M. New therapeutic approaches for metastatic thyroid carcinoma.
BRAF. Genetics Home Reference website. Available at: http://ghr.nlm.nih.gov/gene/BRAF. Updated May 2012. Accessed September 19, 2012.
Cabozantinib. Exelixis website. Available at: http://www.exelixis.com/cabozantinib. Accessed September 19, 2012.
Cooper DS, Doherty GM, Haugen BR, et al. The American Thyroid Association Guidelines Taskforce: management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
Cornett WR, Sharma AK, Day TA, et al. Anaplastic thyroid carcinoma: an overview.
Curr Oncol Rep.
Gupta-Abramson V, Troxel AB, Nellore A, et al. Phase II trial of sorafenib in advanced thyroid cancer.
J Clin Oncol
Pazopanib. PubMed Health website. Available at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0004876/. Accessed September 19, 2012.
Sunitinib. PubMed Health website. Available at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000402/. Accessed September 19, 2012.
Targeted therapy shows benefit in rare type of thyroid cancer. National Cancer Institute website. Available at: http://www.cancer.gov/clinicaltrials/results/summary/2011/vandetanib1211. Accessed September 19, 2012.
Targeted therapy for thyroid cancer. American Cancer Society website. Available at: http://www.cancer.org/Cancer/ThyroidCancer/DetailedGuide/thyroid-cancer-treating-targeted-therapy. Updated January 20, 2012. Accessed September 19, 2012.
Zelboraf. Zelboraf website. Available at: http://www.zelboraf.com/patient/about/index.html. Accessed September 19, 2012.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © 2012 EBSCO Publishing
All rights reserved.
Wellmont LiveWell is creating a new tradition of wellness in the mountains by providing individuals with tools and encouragement to live healthier lifestyles.
Fight heart disease early and prevent heart attacks with HeartSHAPE® - a painless, non-invasive test that takes pictures of your heart to scan for early-stage coronary disease.
How many calories do you need to eat each day to maintain your weight and fuel your physical activity? Enter a few of your stats into this calculator to find out.
Using body mass index as a reference, this calculator determines your ideal body weight range. All you need to do is enter your height.
This tool considers your height and weight to assess your weight status.
Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.
You clicked on a link that will cause you to leave myWellmont.
For security purposes you will be signed out.